2003
DOI: 10.1128/jvi.77.14.7957-7963.2003
|View full text |Cite
|
Sign up to set email alerts
|

Delivery of Adeno-Associated Virus Vectors to the Fetal Retina: Impact of Viral Capsid Proteins on Retinal Neuronal Progenitor Transduction

Abstract: The development of fetal ocular gene transfer may be useful as a therapeutic tool for the prevention of retinal genetic disorders with congenital or early clinical manifestations. In this study we explored the neural progenitor transduction patterns of adeno-associated virus (AAV) vectors following delivery to the developing retina. Recombinant vectors with the same genome carrying the enhanced green fluorescent protein (EGFP) transgene packaged in capsids of differing serotypes (serotypes 1, 2, and 5, termed … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
31
0

Year Published

2004
2004
2011
2011

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 40 publications
(35 citation statements)
references
References 41 publications
(44 reference statements)
4
31
0
Order By: Relevance
“…6). We were able to detect GFP expression in the RPE of injected retinal areas (data not shown), in agreement with the results previously reported for AAV-mediated subretinal delivery at early postnatal stages (Surace et al 2003;Colella and Auricchio 2010).…”
Section: In Vivo Misexpression Of Vax2os1 Affects Retinal Progenitor supporting
confidence: 81%
“…6). We were able to detect GFP expression in the RPE of injected retinal areas (data not shown), in agreement with the results previously reported for AAV-mediated subretinal delivery at early postnatal stages (Surace et al 2003;Colella and Auricchio 2010).…”
Section: In Vivo Misexpression Of Vax2os1 Affects Retinal Progenitor supporting
confidence: 81%
“…Earlier investigations that compared the transduction efficiency of rAAV serotypes in the eye used in vivo fluorescent imaging, fundus luminescence quantification, and in some studies, quantitative PCR. 3,4,[6][7][8]12 Quantitative analysis of immunostained retinal sections has been carried out after intravitreal rAAV2/2 injections, 11 but to our knowledge, this type of analysis has not been used to compare the transduction efficiency and tropism of different rAAV serotypes after injection into the vitreous. When analyzed 10 weeks after a single titre-matched intravitreal injection, we here confirm earlier tropism and transduction findings for rAAV2/2 11 and report new data on six additional rAAV vectors.…”
Section: Discussionmentioning
confidence: 99%
“…2 In the eye, rAAV has been used in experimental studies aimed at treating retinal degenerative diseases or for cell rescue following trauma. [3][4][5][6][7][8][9][10][11][12][13][14] On the basis of the success of some of these animal studies, clinical trials with AAV vectors have recently been initiated in humans with genetically linked ophthalmic diseases. 15,16 Human AAV serotype 2 was originally found as a contaminant in adenovirus preparations 17 and has not been associated with any human pathogenicity.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Detection must depend upon a brief window of time after surgery needed to introduce the vector, perhaps related to a concurrent but transient inflammation. This strategy may be useful in managing other types of rejection in the retina.Numerous investigators have used viral vectors to transduce retinal cells with enhanced green fluorescent protein (EGFP), with no evidence of rejection of this foreign protein (2,3,15,20,21). Similar results have been reported with other reporter genes that express foreign proteins in the retina, such as LacZ (6,8,14).…”
mentioning
confidence: 99%